Literature DB >> 23858303

Skeletal muscle: an endocrine organ.

Alessandra Pratesi1, Francesca Tarantini, Mauro Di Bari.   

Abstract

Tropism and efficiency of skeletal muscle depend on the complex balance between anabolic and catabolic factors. This balance gradually deteriorates with aging, leading to an age-related decline in muscle quantity and quality, called sarcopenia: this condition plays a central role in physical and functional impairment in late life. The knowledge of the mechanisms that induce sarcopenia and the ability to prevent or counteract them, therefore, can greatly contribute to the prevention of disability and probably also mortality in the elderly. It is well known that skeletal muscle is the target of numerous hormones, but only in recent years studies have shown a role of skeletal muscle as a secretory organ of cytokines and other peptides, denominated myokines (IL6, IL8, IL15, Brain-derived neurotrophic factor, and leukaemia inhibitory factor), which have autocrine, paracrine, or endocrine actions and are deeply involved in inflammatory processes. Physical inactivity promotes an unbalance between these substances towards a pro-inflammatory status, thus favoring the vicious circle of sarcopenia, accumulation of fat - especially visceral - and development of cardiovascular diseases, type 2 diabetes mellitus, cancer, dementia and depression, according to what has been called "the diseasome of physical inactivity".

Entities:  

Keywords:  aging; myokine; sarcopenia; skeletal muscle

Year:  2013        PMID: 23858303      PMCID: PMC3710002          DOI: 10.11138/ccmbm/2013.10.1.011

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  49 in total

1.  Inflammatory markers and loss of muscle mass (sarcopenia) and strength.

Authors:  Laura A Schaap; Saskia M F Pluijm; Dorly J H Deeg; Marjolein Visser
Journal:  Am J Med       Date:  2006-06       Impact factor: 4.965

Review 2.  Immunosenescence and immunogenetics of human longevity.

Authors:  R Ostan; L Bucci; M Capri; S Salvioli; M Scurti; E Pini; D Monti; C Franceschi
Journal:  Neuroimmunomodulation       Date:  2008-11-26       Impact factor: 2.492

3.  Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes.

Authors:  T Kanemaki; H Kitade; M Kaibori; K Sakitani; Y Hiramatsu; Y Kamiyama; S Ito; T Okumura
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

Review 4.  What is sarcopenia?

Authors:  W J Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1995-11       Impact factor: 6.053

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.

Authors:  Andrew L Carey; Gregory R Steinberg; S Lance Macaulay; Walter G Thomas; Anna G Holmes; Georg Ramm; Oja Prelovsek; Cordula Hohnen-Behrens; Matthew J Watt; David E James; Bruce E Kemp; Bente K Pedersen; Mark A Febbraio
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

Review 7.  Physical activity and modulation of systemic low-level inflammation.

Authors:  Helle Bruunsgaard
Journal:  J Leukoc Biol       Date:  2005-07-20       Impact factor: 4.962

8.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

9.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

Authors:  R Schindler; J Mancilla; S Endres; R Ghorbani; S C Clark; C A Dinarello
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

Review 10.  Searching for the exercise factor: is IL-6 a candidate?

Authors:  B K Pedersen; A Steensberg; C Fischer; C Keller; P Keller; P Plomgaard; M Febbraio; B Saltin
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

View more
  43 in total

Review 1.  Implications of exercise-induced adipo-myokines in bone metabolism.

Authors:  Giovanni Lombardi; Fabian Sanchis-Gomar; Silvia Perego; Veronica Sansoni; Giuseppe Banfi
Journal:  Endocrine       Date:  2015-12-30       Impact factor: 3.633

Review 2.  The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint.

Authors:  Bette J Caan; Elizabeth M Cespedes Feliciano; Candyce H Kroenke
Journal:  Cancer Res       Date:  2018-04-15       Impact factor: 12.701

Review 3.  Techniques for the diagnosis of sarcopenia.

Authors:  Gaia Rubbieri; Enrico Mossello; Mauro Di Bari
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

4.  [Sarcopenia and frailty in neurology].

Authors:  W Maetzler; M Drey; A H Jacobs
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

5.  Regrowth after skeletal muscle atrophy is impaired in aged rats, despite similar responses in signaling pathways.

Authors:  Jena R White; Amy L Confides; Stephanie Moore-Reed; Johanna M Hoch; Esther E Dupont-Versteegden
Journal:  Exp Gerontol       Date:  2015-02-12       Impact factor: 4.032

6.  Handgrip Strength Cutoff Points to Identify Mobility Limitation in Community-dwelling Older People and Associated Factors.

Authors:  K S de Souza Vasconcelos; J M Domingues Dias; A de Carvalho Bastone; R Alvarenga Vieira; A C de Souza Andrade; M Rodrigues Perracini; R Oliveira Guerra; R Corrêa Dias
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

7.  Clinical impact of body composition on postoperative outcomes during neoadjuvant chemoradiation therapy for distal bile duct cancer.

Authors:  Wataru Fujii; Hiroshi Wada; Shinichiro Hasegawa; Yosuke Mukai; Kei Asukai; Hirofumi Akita; Takahito Sugase; Masaaki Yamamoto; Tomohira Takeoka; Naoki Shinno; Hisashi Hara; Takeshi Kanemura; Naotsugu Haraguchi; Junichi Nishimura; Masayoshi Yasui; Chu Matsuda; Takeshi Omori; Hiroshi Miyata; Masayuki Ohue; Masato Sakon; Hidenori Takahashi
Journal:  Mol Clin Oncol       Date:  2022-05-11

8.  Prevalence and clinical impact of sarcopenia in osteoporotic hip fracture: Single center retrospective cohort study.

Authors:  Won Chul Shin; Jae Hoon Jang; Han Eol Seo; Kuen Tak Suh; Nam Hoon Moon
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

Review 9.  Clinical implications of low skeletal muscle mass in early-stage breast and colorectal cancer.

Authors:  Elizabeth Cespedes Feliciano; Wendy Y Chen
Journal:  Proc Nutr Soc       Date:  2018-06-04       Impact factor: 6.297

10.  Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact.

Authors:  Willian A da Silveira; Hossein Fazelinia; Sara Brin Rosenthal; Evagelia C Laiakis; Man S Kim; Cem Meydan; Yared Kidane; Komal S Rathi; Scott M Smith; Benjamin Stear; Yue Ying; Yuanchao Zhang; Jonathan Foox; Susana Zanello; Brian Crucian; Dong Wang; Adrienne Nugent; Helio A Costa; Sara R Zwart; Sonja Schrepfer; R A Leo Elworth; Nicolae Sapoval; Todd Treangen; Matthew MacKay; Nandan S Gokhale; Stacy M Horner; Larry N Singh; Douglas C Wallace; Jeffrey S Willey; Jonathan C Schisler; Robert Meller; J Tyson McDonald; Kathleen M Fisch; Gary Hardiman; Deanne Taylor; Christopher E Mason; Sylvain V Costes; Afshin Beheshti
Journal:  Cell       Date:  2020-11-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.